New Data Reveal Molecular Drivers of Thyroid Eye Disease (TE

-- Oral presentation at AAO 2022 suggests IGF-1 and its related pathways are extensively upregulated throughout all stages of TED --DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of new data defining molecular patterns in TED and further implicating the role of insu...

Related Keywords

United States , Jules Stein Eye Institute , California , Los Angeles , Chicago , Illinois , American , Jeffreyw Sherman , Tina Ventura , Shoaib Ugradar , Rachel Vann , Instagram , Product Communications , Linkedin , Twitter , Visa , American Academy Of Ophthalmology , Nasdaq , American Academy Of Ophthalmology Annual Meeting , European Group On Grave Orbitopathy , Facebook , Horizon Therapeutics , American Academy , Ophthalmology Annual Meeting , Thyroid Eye Disease , Genome Transcriptome Comparison , Chronic Thyroid Eye Disease , Thyroid Associated , Grave Disease Is Mediated Through , Insulin Like Growth Factor , Grave Orbitopathy , Clinical Practice Guidelines , Medical Management , European Group , Vice President , Chief Investor Relations Officer ,